I have read this news article – it looks like MS will be field of big epic battles in the nearest future. The market is very impressive!
MS is an autoimmune disease that affects about 2.1 million people worldwide …
Avonex, made by Biogen, Bayer’s Betaseron and Merck KGaA (MRK)’s Rebif generated $6.6 billion in 2011 revenue, according to data compiled by Bloomberg. Called disease-modifying drugs, they have been shown to slow the frequency of relapses and reduce the development of brain lesions. Their ability to slow disability progression has been less clear, wrote the researchers
No comments:
Post a Comment